Tracking the Pulse of Clinical Trials in India
IndiaTrialPulse is a monthly clinical trial intelligence initiative by StriderDCT designed to decode emerging trends across India’s evolving clinical research ecosystem.
Built using insights from the Clinical Trials Registry of India (CTRI), IndiaTrialPulse tracks multi-site clinical trial activity across therapeutic areas, sponsor participation, geographic distribution, and operational trends.
As India’s clinical research landscape continues to expand, the need for structured, data-driven visibility has become increasingly important for sponsors, CROs, clinical operations teams, and healthcare stakeholders.
Through consistent monthly tracking and analysis, IndiaTrialPulse aims to bring clarity to the signals shaping India’s clinical trial ecosystem.
January 2026 Clinical Trial Trends
Oncology Leads India’s Multi-Site Research Activity
India’s clinical research ecosystem entered 2026 with steady momentum, reflecting growing adoption of multi-site clinical trials and increasing sponsor participation.
The January edition of IndiaTrialPulse by StriderDCT analyzes trends emerging from the Clinical Trials Registry of India (CTRI) across multi-site studies.
Key Highlights
- 38 multi-site trials were registered in January
- Oncology emerged as the leading therapeutic area
- Women’s Health, CNS, Gastroenterology, and Immunology also showed notable activity
- North, West, and South India remained key trial regions
What This Indicates
January highlighted the continued expansion of India’s clinical research ecosystem, with sponsors increasingly adopting distributed trial models and broader therapeutic diversification.
The growing participation from non-metro regions also signals improving clinical research infrastructure across India.
IndiaTrialPulse continues to track these evolving trends through structured, data-driven insights.
